ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022: The ImPrint Immune Signature to Identify Patients With High-Risk eBC Who May Benefit From PD-1 Checkpoint Inhibition in I-SPY2
By
ASCO 2022 Conference Coverage
FEATURING
Lorenza Mittempergher
By
ASCO 2022 Conference Coverage
FEATURING
Lorenza Mittempergher
30 views
June 8, 2022
Login to view comments.
Click here to Login
Breast